Beijing, China

Fangfang Lai


 

Average Co-Inventor Count = 7.5

ph-index = 4

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2020-2025

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Fangfang Lai: Innovator in Pharmaceutical Chemistry

Introduction

Fangfang Lai is a prominent inventor based in Beijing, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 5 patents, her work focuses on innovative solutions for treating diseases related to the PD-1/PD-L1 signaling pathway.

Latest Patents

Fangfang Lai's latest patents include groundbreaking inventions such as the maleate of nicotinyl alcohol ether derivative and its crystal form. This invention relates to the technical field of medicine and provides a method for preparing a compound that can be used in treating various diseases, including cancer and autoimmune disorders. Another notable patent involves the nicotinyl alcohol ether derivative, which also addresses treatment methods for diseases associated with the PD-1/PD-L1 signaling channels.

Career Highlights

Throughout her career, Fangfang has worked with esteemed organizations such as the Chinese Academy of Sciences and Tianjin Chase Sun Pharmaceutical Co., Ltd. Her experience in these institutions has allowed her to refine her expertise in pharmaceutical research and development.

Collaborations

Fangfang has collaborated with notable colleagues, including Zhiqiang Feng and Xiaoguang Chen. These partnerships have contributed to her innovative research and the successful development of her patented inventions.

Conclusion

Fangfang Lai's contributions to pharmaceutical chemistry exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a key figure in the development of treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…